Call Chat

Bladder Cancer


Bladder Cancer

Bladder Cancer Treatment in Gurgaon India

Bladder cancer is the most common cancer of the urinary system. It is quite common throughout the world with the US alone reporting 79, 030 cases and 16, 870 deaths in the year 2017. In developing nations like India and other countries in South East Asia, this risk is almost twice as high as per review from the PubMed library. This significantly states the need for early diagnosis and treatment.

How do I know if I am at risk for Bladder Cancer? What are the causes of Bladder Cancer?

Following are some of the risk factors for bladder cancer. If you have one or more of the following, you may be at risk.

Age, Gender and Ethnicity

Older age individuals especially males are generally at increased risk of developing bladder cancer with most of the incidences observed in the 6th, 7th, and 8th decades of life.

Whites are about twice as likely to develop bladder cancer as African Americans. Asian Americans and American Indians have slightly lower rates of bladder cancer.

Tobacco/Cigarette smoking

Use of tobacco is one of the major risk factors for bladder cancer with the higher risk involved for more amount used over a short duration. Smokers are at 3 times higher risk of developing bladder cancer compared to non-smokers. The incidence increases with the intensity and duration of smoking.

Family history

Risk of developing bladder cancer increases in an individual with a history of bladder cancer in first-degree relatives (parents, brother, sister, or child). Previous history of bladder cancer in the family may increase the risk in other family members.

Genetic Cancer Predisposition Syndromes

Following are some examples:

  • Lynch syndrome or hereditary non-polyposis colorectal cancer (HNPCC, generally caused by a mutation in the MLH1 or MSH2gene);
  • Cowden disease (caused by a mutation in PTEN/MMAC1 gene); and
  • Mutations in retinoblastoma (Rb1), SLC14A1 (a urea transporter gene), GSTM1, and NAT2.

Personal History

Individuals with a personal history of cancer in the lining of any part of the urinary tract are generally at higher risk of developing another cancer.

Previous history of cancer treatment with certain chemotherapy agents or radiation may also predispose to bladder cancer.

Occupational exposure

Higher risk of bladder cancer is also associated with regular exposure to certain chemicals like paint, dye, heavy metals, or petroleum products generally experienced by dyestuffs workers, painters, leather workers, truck drivers, aluminum workers and workers in the dry-cleaning industry.

Previous Treatments

History of exposure to radiation and treatment with certain drugs like cyclophosphamide, ifosfamide, phenacetin, and pioglitazone is reported to be the independent risk factors for bladder cancer.


Infection with Schistosoma haematobium (a parasitic worm that is prevalent in certain parts of Africa and the Middle East) is associated with an increased risk of bladder cancer.

Exposure to a high level of arsenic or chlorine in drinking water can also increase the risk of bladder cancer.

Chronic irritation of bladder

Chronic irritation by urinary tract infection, kidney/bladder stones, or prolonged use of catheters have also been linked to a high incidence of bladder cancer.

Other Factors

Diabetes mellitus (especially type 2 diabetes), heavy alcohol consumption, high intake of coffee/tea, artificial sweeteners, and low intake of water are some other risk factors postulated for bladder cancer.

What are the Symptoms and Signs of Bladder Cancer? How do I know if I have Bladder Cancer or not?

But, how will you seek treatment if you don’t suspect bladder cancer in the first place? To meet this gap, we will introduce you to the symptoms of bladder cancer so that you can easily speculate your risk.

Bladder cancer may present with any one or more of the signs or symptoms mentioned below. These may vary depending on the extent of disease, location of bladder tumor, site of metastasis, etc.

Sometimes, other conditions may present in a similar manner. So, it is important to consult your doctor if you notice any of these symptoms and undergo thorough testing.

Early Symptoms of Bladder Cancer

Blood in Urine (Hematuria)

Bladder Cancer doctor in gurgaon: In most cases, haematuria is the first sign of advanced bladder. It may in the form of microscopic or gross hematuria. Microscopic haematuria is the presence of blood in urine, which may not be visible to your naked eye. Gross hematuria is, the presence of blood in your urine, which will be very much visible to the naked eye. It may be in the passage of blood clots in urine in some cases. In other cases, it may simply be seen as change in the colour or your urine to a reddish colour.

The American Cancer Society classified this colour to be ranging from orange or pink to red and dark red, the latter being relatively uncommon.

You must note that you need not wait until you notice blood in your urine each day before suspecting bladder cancer. You may notice it on a day and then may not see it again for months. In most cases, there will be very little to no pain.

Increased Frequency of Urination (Poluuria)

You may feel the urge to feel more often than usual. Maybe at every hour or several times of the day. Further, you may repeatedly wake up at night to urinate or may face difficulty in sleeping because of frequent awakenings due to this desire.

It may be due to the bladder mass obstructing the urine flow causing incomplete emptying of the bladder. It may also be due to urinary tract infection causing bladder irritation leading to frequent passing of urine.

Burning or Painful Urination

Burning urination may be due to urinary tract infections, occuring as a result of long term retention of urine in bladder. This may be associated with increased frequency of urination also.

Painful urination and difficulty in urinating despite the presence of desire to urinate may occur due to bladder neck mass causing obstruction in the flow of urine.

General Symptoms

Constitutional symptoms like fatigue, weight loss, loss of appetite and/or diminished desire to participate in daily activities such as going to work, exercise, etc may occur as a result of bladder cancer or coexistent urinary infections.

Symptoms of Late or Advanced Stage Bladder Cancer

Late stages of bladder cancer include cases with locoregional involvement of nearby structures and distant spread of the tumor. In addition to ones mentioned above, these may be one or more of the following-

Heaviness or Pain in Abdomen

Presence of a lower abdominal or pelvic mass, which may or may not be painful may be an indication of bladder cancer that has spread to surrounding areas. Or else, it may occur due to the spread of cancer to lymph nodes in lower abdomen.

Involvement of intestine may cause intestinal obstruction leading to constipation and feeling of heaviness in abdomen or bloating sensation.

Obstruction to the flow or passage of urine may cause bladder fullness that may cause discomfort in the pelvic region. Sometimes, bladder mass close to vesico-urteral junction may cause hydronephrosis and pain in back or loin region.


Spread of bladder cancer to liver may cause jaundice or yellowish discoloration of eyes and/or urine. It may sometimes be associated with pruritus or generalised itching over the body.

Breathlessness or Cough

Breathing difficulty, excessive coughing and/or pain on deep breathing may be a sign of bladder cancer spread to lungs or pleura (causing fluid accumulation around the lungs).

Pain at Bony Sites

Sometimes, spread of bladder cancer to one or more bones may cause pain in back, ribs, etc.

Urinary tract infection is one of the commonest benign differential diagnosis of bladder cancer. As we have already discussed above, early symptoms of bladder cancer such as increased frequency of urination, nocturia, burning sensation during passage of urine are the most common symptoms of urinary tract infections also. Moreover, microscopic or macroscopic hematuria may also be seen in some cases of UTI.

So, bladder cancer, especially in early stages could easily be mistaken for UTI. A high level of suspicion and adequate diagnostic work-up is very important to differentiate between the two.

What are the Tests or Investigations to be done to confirm the diagnosis of Bladder Cancer?

When someone is suspected of bladder cancer based on presence of signs or symptoms, certain diagnostic investigations are required to confirm and stage the disease. These diagnostic tests discussed below help us confirm the presence of bladder tumor, and also other details, like type of tumor, number, depth of invasion, involvement of regional lymph nodes, and spread to distant sites. All this information helps the oncologist to take an appropriate treatment decision. The infographic below lists some of the investigations.

Now, let’s discuss the diagnostic and staging investigations one by one.


Urinalysis helps us detect the presence of blood cells (RBCs) in urine. Patients with bladder cancer may have hematuria (blood in urine). It may be grossly visible (macroscopic hematuria) or may be detected only on microscopic examination of the urine sample (microscopic hematuria).

Urinalysis can detect the presence of blood in urine that may be an early sign of bladder cancer in an individual and may help in early diagnosis of the disease.

Apart from this, urine culture is also performed to exclude any possibility of urinary tract infection that can also produce symptoms similar to that of bladder cancer.

Urine Cytology

Bladder Cancer surgeon in gurgaon: In this test, a urine sample is checked for the presence of abnormal (precancerous or cancerous) cells using a microscope. Presence of abnormal cells may indicate diagnosis of cancer in the urinary tract. Further investigation is required to find the location of the tumor.

The urine sample for cystoscopy may be collected by voiding, but in that case the sensitivity of the test is very low. The other method that may improve the sensitivity of urine cytology is cystscopic irrigating the bladder with a sterile liquid and then checking that fluid for malignant cells. But despite that also, many cases of bladder cancer may not show positive cytology.

Urine Tests for Tumor Markers

With the advancement of science, newer tests are now available to check the presence of certain markers in the urine which may suggest bladder cancer. For example, Telomerase (an enzyme usually found in cancer cells), bladder tumor-associated antigen (BTA), carcinoembryonic antigen (CEA), and NMP22 protein. But these tests are not very reliable and may provide with a supportive evidence of the tumor.


Bladder Cancer treatment in gurgaon: Cystoscopy is a diagnostic technique which uses a cystoscope – a long, flexible, slender tube usually equipped with a camera, a light source, and some special instruments for biopsy or surgery. This enables to look inside the bladder by passing the cystoscope into the bladder via urethra to determine the presence and extent of the disease. Also, it helps in transuretheral resection of bladder tumor which is both, diagnostic as well as therapeutic.

As you can see in this figure, only cancer containing superficial layers of the bladder is removed, without damaging the deeper layers.

Transurethral resection of bladder tumor (TURBT)

If the abnormal area(s) are observed during cystoscopy, biopsy samples are collected from the abnormal area through a transurethral resection of bladder tumor (TURBT) or transurethral resection (TUR) technique. The tumor along with underlying muscle tissue is removed to check the extent of invasion into the bladder wall. Multiple biopsies may be obtained depending upon the cystoscopy observations. This technique helps in establishing the stage of the disease.

Intravenous Pyelogram

In this technique, various x-ray images are taken of the urinary system after injecting a contrast (dye) into patient’s vein. The dye outlines the complete urinary system on the x-ray images and is excreted in the urine by kidneys. This helps the doctor to examine the urinary tract for any abnormal areas. In some cases, we may require a Retrograde Pyelogram in which a dye is injected into the ureter with the help of cystoscope, followed by a series of images.

CT Scan or MRI

Bladder Cancer treatment in gurgaon: Pyelogram may be complemented with other imaging modalities, like CT scan or MRI, which help in better delineating the urinary tract. Also, CT scan or MRI of the abdomen and pelvis helps to understand the local extention of the tumor to other structures and the involvement of regional lymph nodes. It also helps to diagnose the metastatic involvement of other structures.

Distant imaging of other parts of the body like bones, lungs, etc may be needed in some cases, especially when the bladder tumor is muscle-invasive, or has invaded into the muscle layer of the bladder. Also if there are symptoms suggestive of distant organ involvement. In such cases, further testing may be required like, CT chest, bone scan, whole bodt PET CT scan , etc.

How do I know my Stage of Bladder Cancer?

The bladder is an inflatable, hollow muscular organ situated in the pelvis. The main function of the bladder is to store urine until it is excreted from the body through the urethra. In a normal adult, it can hold up to 800 mL of urine.

The walls of urinary bladder consist of mainly three layers: mucosa (made up of transitional epithelium cells), lamina propria (made up of connective tissue), and muscularis propria (made up of 3 layers of smooth muscle fibers). Staging for bladder cancer is called as TNM staging system. It helps in disease prognostication and choosing an appropriate treatment strategy.

Stage 0

Stage 0 bladder cancer includes cases of TaN0M0 and TisN0M0. This means Tis or Ta disease (as discussed below) without the involvement of regional nodes or distant spread of tumor. Tis is the carcinoma in situ which is a flat tumor limited to the epithelium.

Stage 1

Stage 1 bladder cancer includes cases with T1N0M0 disease, that it T1 disease (as discussed below) without involvement of regional nodes or distant spread. The layer of the bladder wall outside the epithelium is called as lamina propria. Both Tis and Ta are the non-invasive sub-types of bladder cancer. When the tumor infiltrates into the lamina propria it is called T1.

Stage 2

Stage 2 includes cases with T2N0M0 disease, that it T2 disease (as discussed below) without spread to regional lymph nodes or distant organs.

To understand it better, let’s see the layers of the bladder wall first. Outer to lamina propria lies this layer, called an inner muscle layer. inner muscle layer And on the outermost aspect lies the outer muscle layer. outer muscle layer. When bladder cancer infiltrates into the inner muscle layer, it is called as T2a and T2b when it infiltrates into the outer muscle layer.

Stage 3

Stage 3 tumor can be further classified into Stage 3a and Stage 3b.

Stage 3 includes cases of T3N0M0, T4aN0M0, T1-4aN1-3M0.

When the tumor infiltrates through the bladder wall to involve the perivesical tissue it is called as T3 disease. T3 disease without involvement of regional nodes or spread to distant organs is Stage 3a disease.

Also, when the bladder cancer extends outwards to involve the nearby structures, like prostate, uterus, vagina, or seminal vesicles (T4a disease), without spread to regional lymph nodes or distant sites, it comes under stage 3 disease. It may extend downwards to infiltrate prostate gland in male.

Also, stage 3 bladder cancer includes cases of T1 to T4a disease (as discussed above), but with one or more regional lymph node positive (perivesical, obturator, internal or external iliac, sacral or common iliac lymph node).

Depending upon the number and location of the lymph nodes involved, it can be N1, N2, or N3.

  • N1 – Involvement of one regional lymph node in true pelvis
  • N2 – Involvement of multiple regional lymph node in true pelvis
  • N3 – Involvement of common iliac lymph nodes

The involvement of any lymph node(s) by bladder cancer makes it stage 3 disease.

Stage 4

Bladder cancer may also extend laterally to involve the pelvic or abdominal wall, as shown in the figure below. This is called as T4b disease, and is included in stage 4a bladder tumor.

Stage 4b includes tumor spread to one or more distant organs such as lungs, bones, liver, peritoneum, etc (M1b).

Bladder cancer metastasis to distant sites largely depends on the extent of local infiltration, i.e. whether it is non-muscle invasive or muscle invasive. The muscle invasive bladder cancer has a higher likelihood of spread, owing to increased chances of cancer cells entering into systemic circulation. It also depends on the histology of bladder cancer, whether it is transitional cell or of atypical histology. Usually, atypical histology has a higher chance of distant metastasis.

The most common sites of metastasis in decreasing order are lymph nodes, bone, lung, liver and peritoneum. The sites of metastasis is usually similar in different T stages, but in atypical histology tumors, peritoneal metastasis is more common than transitional cell histology.

Distant metastases from bladder cancer may occur to the bones. Or to the liver in the form of multiple nodular deposits.

Based on the TNM staging discussed above, bladder cancer may be classified into 4 stages as mentioned below.

0a Ta N0 M0
0is Tis N0 M0
I T1 N0 M0
II T2a N0 M0 , T2b N0 M0
IIIa T3 N0 M0 , T4a N0 M0 , T1-4a N1 M0
IIIb T1-4a N2-3 M0
IVa T4b Any N M0, Any T Any N M1a
IVb Any T Any N M1b

What is the Treatment for Bladder Cancer? Where can I get the best treatment for Bladder Cancer in Gurgaon?

Treatment of bladder cancer depends on the stage, type, unifocal/multifocal, performance status of the patient, along with other factors. But the final treatment decision is taken by the oncologist after clinical evaluation of the patient.

Oncoexperts is a cancer clinic in Gurgaon for treatment for bladder cancer from our team of cancer experts that include surgical oncologists, medical oncologists, and radiation oncologists who are experts in treating all types of bladder cancer.

First step is to a cystoscopy. In this technique, a hollow tube called a cystoscope which is fitted with a camera is inserted into the urethra and is slowly advanced into the bladder. It helps to confirm the presence of a bladder tumor and see its location, number, and extent. Also, it helps in transurethral resection of bladder tumor which is both diagnostic and therapeutic.

As you can see in this figure, only cancer containing superficial layers are removed, without damaging the deeper layers.

This helps us to determine whether the bladder tumor is Non-Muscle invasive or Muscle invasive.

Treatment Based on Stage

Stage 0

This is carcinoma in situ which is a flat tumor, limited to the epithelium.

Intravesical chemotherapy should be given in all cases of This disease. As you can see in the figure, in this procedure the chemotherapy drug is directly instilled into the bladder, with the help of a catheter.

For Ta disease also, intravesical chemotherapy may be given. But in some cases, intravesical chemotherapy may not be required, when we can keep the patient under observation.

It is generally employed as intravesical therapy after transurethral resection of bladder tumor (TURBT) or after surgical resection of some early-stage, high-grade, non-muscle invasive bladder cancers to prevent recurrence.

Induction intravesical BCG therapy is usually given once a week for 6 weeks. Two or more rounds of BCG induction therapy may be employed with a treatment-free interval of 4 to 6 weeks. Maintenance therapy with a monthly BCG dosing for about 1 to 3 years may be employed in some patients with high risk of disease recurrence.

Stage 1

Stage 1 bladder cancer includes cases with T1 disease without any regional lymph nodes involvement or distant spread.

When the tumor infiltrates into the lamina propria, it is called as T1.

For T1 disease, the treatment depends on whether the tumor is low grade or high grade. Intravesical chemotherapy is the treatment of choice for low-grade tumors.

Whereas, in high-grade tumors, apart from intravesical BCG, repeat TURBT is strongly advised.

High risk cases of T1 disease includes those with multifocal lesions, lymphovascular invasion, those associated with carcinoma in situ or having a variant high risk histology (micropapillary, nested or plasmacytoid). It also includes cases that recur after intravesical BCG. In such cases high-risk cases, the preferred modality of treatment is cystectomy or surgical resection of the bladder.

Stage 2

Stage 2 bladder cancer includes cases with T2 disease, without the involvement of regional lymph nodes or distant spread of the tumor.

When it infiltrates into the inner muscle layer, it is called as T2a. And T2b, when it infiltrates the outer muscle layer.

For T2 disease, radical cystectomy is advised. It involves cystoprostatectomy in men that includes the removal of bladder, prostate, proximal part of urethra and vas deferens. Whereas, in women, it usually involves the removal of prostate and uterus, along with fallopian tubes, ovaries, part of vagina and urethra. Resection of pelvic lymph nodes is always done in radical cystectomy.

Partial cystectomy is an option in some selected cases, when bladder tumor is located such that it can be removed with adequate margins without removing the complete bladder, eg. tumor at the dome of bladder. Also, there should be no area of carcinoma-in-situ elsewhere in bladder.

Bladder preserving approach may be considered in selected cases depending on size, location, depth of bladder tumor, condition of the patient along with other factors. Treatment in such cases is done with concurrent chemoradiation.

Chemotherapy should be considered in cases of stage 2 disease. It should be preferably given before the surgery (neoadjuvant chemotherapy). If not given in the neoadjuvant setting, then should be given after the surgery (adjuvant chemotherapy).

Stage 3

Stage 3 includes cases of T3N0M0, T4aN0M0, T1-4aN1-3M0.

Till T2, the tumor is limited to the bladder wall. But when the tumor infiltrates through the bladder wall to involve the perivesical tissue, it is called T3.

And in T4 disease, the tumor infiltrates through the bladder wall to involve the adjacent structures. It may extend downwards to infiltrate prostate gland in males.

For T3 disease, and selected patients of T4 disease, as discussed above, with nodes negative, the preferred modality of treatment is cystectomy, with chemotherapy, which may be given before or after surgery.

But for non-cystectomy candidates, in which we are not planning surgery, a combination of chemotherapy and radiotherapy may be used.

The tumor may also extend anterolaterally, to involve pelvic or abdominal wall.

Depending upon the number and location of the nodes involved, it can be N1, N2 or N3. In selected patients of T4 disease, with abdominal or pelvic wall extension, and any patient with the node-positive disease, the preferred modality of treatment is chemotherapy, with or without radiation therapy. And further therapy maybe decided to depend upon the response to initial treatment. Stage 4 Bladder Cancer Treatment Now let’s come to the treatment for stage 4 or metastatic bladder tumor. Distant metastasis from bladder cancer may occur to the bones. Or to the liver in form of multiple nodular deposits.

Chemotherapy or immunotherapy is the mainstay of treatment for metastatic disease. But other modalities like surgery, radiation therapy, or bone-directed therapy may be used for palliation or relief of symptoms.

Chemotherapy drugs that are part of bladder cancer treatment regimens are-

  • Gemcitabine
  • Cisplatin
  • Carboplatin
  • Methotrexate
  • Doxorubicin
  • Vinblastine
  • Paclitaxel
  • Ifosfamide

What is the Role of Immunotherapy in Bladder Cancer?

Atezolizumab, an PD-L1 inhibitor, has been approved as the first-line therapy for patients with locally advanced or metastatic bladder cancer who are not eligible for any platinum-containing chemotherapy, regardless of the PD-L1 expression level.

Pembrolizumab, Atezolizumab, Nivolumab, Durvalumab, and Avelumab. These immune-checkpoint inhibitors have been approved as the second-line treatment of locally advanced or metastatic urothelial cell carcinoma (most common type of bladder cancer) that has progressed on or after platinum-based chemotherapy. These agents can be employed for the treatment of patients who have progressed within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. The PD-L1 expression levels estimation is not a pre-requisite for employing these agents as second-line treatment.

Always remember that metastatic disease is not generally curative. So the intent of the treatment is a prolongation of life, reduction of symptoms, and improvement in the quality of life of the patient.

Where can I find the best specialists for Bladder Cancer treatment in Gurgaon?

Dr Sunny Garg is a renowned Medical Oncologist in Gurgaon with an experience of around 10 years of treating bladder cancer patients. He has treated bladder cancer patients with Chemotherapy, Targeted Therapy, Immunotherapy and Personalized Cancer Treatment. He is currently practicing at Sanar International Hospitals, Golf Course Road, Gurgaon.

Call or watsapp +91 9686813020 for appointment.

dr sunny clinic
Sunny Garg
Dr. Sunny Garg

Best Oncologist in Gurgaon & Cancer Specialist - Oncoexperts

Dr Sunny Garg is a renowned Medical Oncologist in New Delhi with an experience of more than 10 years of treating cancer patients.

He has studied in one of the most reputed educational institutes of India. He has done his MBBS and MD Internal Medicine from Institute of Medical Sciences, Banaras Hindu University. Thereafter, he has undergone training in Medical Oncology (DM Medical Oncology) from Kidwai Memorial Institute of Oncology, Bengaluru. He has worked in leading cancer centers in Delhi, and currently practicing at Manipal Hospital, Dwarka, New Delhi.

Dr Sunny Garg has extensive knowledge and experience in the field of oncology, and has treated all cancer types, in various stages, including hard to treat cases. He is well versed with various modalities for cancer treatment like Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy and Personalised Cancer Therapy.